Current:Home > ContactNorth Carolina Medicaid recipients can obtain OTC birth control pills at pharmacies at no cost -Quantum Capital Pro
North Carolina Medicaid recipients can obtain OTC birth control pills at pharmacies at no cost
View
Date:2025-04-15 18:08:48
CHAPEL HILL, N.C. (AP) — North Carolina Medicaid recipients can begin receiving over-the-counter birth control pills at no cost this week through hundreds of participating pharmacies.
The oral conceptive Opill will be covered and available without a prescription to Medicaid enrollees starting Thursday at more than 300 retail and commercial pharmacies in 92 of the state’s 100 counties, Gov. Roy Cooper’s office said.
The coverage emerged from a 2021 law that let pharmacists prescribe different kinds of contraception in line with state medical regulations. North Carolina Medicaid began signing up pharmacists to become providers in early 2024, and the state formally announced the Medicaid benefit two weeks ago.
“North Carolina is working to expand access to health care and that includes the freedom to make decisions about family planning,” Cooper said in a news release. He discussed the coverage Wednesday while visiting a Chapel Hill pharmacy.
Opill is the first over-the-counter oral contraception approved by federal drug regulators. Pharmacy access could help remove cost and access barriers to obtaining the pills, particularly in rural areas with fewer providers who would otherwise prescribe the birth control regimen, the governor’s office said. Medicaid-enrolled pharmacies will be able to submit reimbursement claims.
The state’s overall Medicaid population is nearly 3 million. Fifty-six percent of the enrollees are female.
veryGood! (71328)
Related
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- An eco trio, a surprising flautist and a very weird bird: It's the weekly news quiz
- 'Laguna Beach' star Stephen Colletti gets engaged to reporter Alex Weaver: 'Yes! Forever'
- Medical experts are worried about climate change too. Here's how it can harm your health.
- Elon Musk's skyrocketing net worth: He's the first person with over $400 billion
- Raise a Glass to This Heartwarming Modern Family Reunion
- Nevada to pay $340,000 in settlement over prison firefighting conditions
- Argentina’s Peronist machine is in high gear to shore up shaky votes before the presidential runoff
- NHL in ASL returns, delivering American Sign Language analysis for Deaf community at Winter Classic
- Judge rules against tribes in fight over Nevada lithium mine they say is near sacred massacre site
Ranking
- Toyota to invest $922 million to build a new paint facility at its Kentucky complex
- Powerball winning numbers for Wednesday drawing: Jackpot rises to $280 million
- Matson’s journey as UNC’s 23-year-old field hockey coach reaches the brink of another NCAA title
- U.S. military veterans turn to psychedelics in Mexico for PTSD treatment
- Jorge Ramos reveals his final day with 'Noticiero Univision': 'It's been quite a ride'
- Week 12 college football predictions: Picks for Oregon State-Washington, every Top 25 game
- Suspect in custody after a person was shot and killed outside court in Colorado Springs, police say
- School resumes for 'Abbott Elementary': See when 'American Idol,' 'The Bachelor' premiere
Recommendation
House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
Shohei Ohtani, baseball’s 2-way star, becomes first 2-time unanimous MVP
Could America’s giant panda exodus be reversed? The Chinese president’s comments spark optimism
'NCAA doesn't care about student athletes': Fans react as James Madison football denied bowl again
DeepSeek: Did a little known Chinese startup cause a 'Sputnik moment' for AI?
Rep. George Santos won’t seek reelection after scathing ethics report cites evidence of lawbreaking
The Supreme Court won’t allow Florida to enforce its new law targeting drag shows during appeal
Aid to Gaza halted with communications down for a second day, as food and water supplies dwindle